Nurulimab Biosimilar (CTLA-4 / CD152 Reference Antibody)
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma.
Product Specifications
Target
Nurulimab Biosimilar (Anti-CTLA-4 / CD152 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-N378965-1MG 1 mg
Naringenin 7-O-beta-D-Glucuronide Sodium Salt (Mixture of Diastereomers)
Sign In for Pricing
View Details 
BNC942408-100 1x 100 µL
CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741860-100 1x 100 µL
MUC16 / CA125 (Ovarian Carcinoma Marker) (MUC16/1860), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details